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Introduction {#sec001}
============

Urinary incontinence, defined by the International Continence Society as a complaint of any involuntary leakage of urine \[[@pone.0237518.ref001]\] comprises two main types; urethral (non-fistulous) and extra urethral (fistulous). It is a common problem with a global prevalence of 4.8%-54.8% \[[@pone.0237518.ref002]\] and negative effects on quality of life with respect to social life, personal relationship, feelings, sleep and energy \[[@pone.0237518.ref003], [@pone.0237518.ref004]\]. Coyne and colleagues \[[@pone.0237518.ref005]\] reported estimated costs of overactive bladder with urgency urinary incontinence of US\$65.9 billion in 2007 with projected cost of US\$82.6 billion in 2020 in the United States.

The wide reported prevalence stems from differences in definitions, target populations, and methodology in various studies \[[@pone.0237518.ref002]\]. Studies with broad definition of incontinence such as "any loss of urine in the past 12 months" had higher prevalence than those defining urinary incontinence over a shorter period of time such as "two or more bedwetting episodes in the past month" \[[@pone.0237518.ref002]\].

Age, race, obesity, parity, previous hysterectomy, smoking, alcohol consumption, chronic cough, chronic constipation, assisted delivery and other characteristics and practices have been reported to be associated with an increased occurrence of urinary incontinence \[[@pone.0237518.ref002], [@pone.0237518.ref006]--[@pone.0237518.ref011]\].

The three main subtypes of urinary incontinence in women are stress, urgency and mixed urinary incontinence. For the population as a whole stress urinary incontinence is the most common among the three subtypes. The prevalence of stress incontinence however peaks around the fifth decade of life and thereafter the prevalence of urgency and mixed incontinence continue to increase with mixed incontinence being the most prevalent subtype in older women \[[@pone.0237518.ref012], [@pone.0237518.ref013]\].

Non-fistulous urinary incontinence has been studied extensively in Europe, China and United States of America \[[@pone.0237518.ref002], [@pone.0237518.ref006]--[@pone.0237518.ref009], [@pone.0237518.ref014]--[@pone.0237518.ref016]\].

Similarly, prevalence of 5.2%-39% has been reported in some African studies \[[@pone.0237518.ref017]--[@pone.0237518.ref020]\].

In Ghana, the concern has been on urinary incontinence from obstetric fistula \[[@pone.0237518.ref021], [@pone.0237518.ref022]\] and very little research has been done on the subject of non-fistulous incontinence. Literature search revealed only one published study in Ghana by Adanu et al who reported a 22.5% self-reported prevalence and 41.5% prevalence for demonstrable stress incontinence among women with full bladder at an ultrasound clinic \[[@pone.0237518.ref023]\]. The higher prevalence of demonstrable stress incontinence may be an overestimate as women with an uncomfortably full bladder may leak urine on coughing even though that might not be the situation under normal conditions. It may also be that women do not often report the condition because it is not deemed worrisome or out of embarrassment \[[@pone.0237518.ref019]\]. In addition, the study did not report on whether incontinence affected the quality of life of participants.

The paucity of epidemiologic data on non-fistulous incontinence in Ghana potentially creates the impression the condition is not a problem in the country. The result is that little or no advocacy is done about non-fistulous incontinence. Women are not educated about the causes and treatment options available to them. Many clinicians are not familiar with current information on appropriate evaluation and treatment of urinary incontinence and treatment centres lack the necessary resources to effectively manage affected women.

An assessment of the prevalence and determinants of non-fistulous urinary incontinence as well as its self-reported interference with everyday life activities of those affected was conducted among women visiting an out-patient gynaecology clinic at a tertiary facility in the middle belt of Ghana.

Materials and methods {#sec002}
=====================

An analytical cross-sectional study was conducted among women aged ≥18 years who accessed care at the gynaecology out-patient clinic of the Komfo Anokye Teaching Hospital in Kumasi between 1^st^ January and 31^st^ March 2015. Total attendance to the gynaecology clinic in 2013 was 7000 (KATH, Biostatistics Unit). Komfo Anokye Teaching Hospital is the second largest teaching hospital in Ghana and a major referral centre for hospitals in the central and northern parts of Ghana

The sample size, N, was estimated using the formula N = Z^2^pq/d^2^ where;

Z is reliability coefficient (at 95% confidence interval and 5% level of significance, Z is 1.96),

p is the population proportion of the factor under investigation; in this study p is the prevalence of urinary incontinence;

q = 1-p and

d is the desired difference between the actual population proportion and what the study will realize.

Assuming the global prevalence of 54.8% \[[@pone.0237518.ref002]\]; at a desired difference of 5%, a sample size of 381 was estimated as follows N = 1.96^2^×0.54×0.46 / 0.05^2^ = 381. This figure was approximated to 400 assuming a non-response rate of 5%.

A study in Ghana \[[@pone.0237518.ref023]\] reported a 41.5% prevalence of demonstrable stress urinary incontinence. However, a high-end global prevalence of 54.8% was chosen to allow for a conservative overestimation to ensure adequate sampling.

Between 1^**st**^ January 2015 and 31^**st**^ March 2015, all women accessing care at the gynaecology clinic irrespective of presenting complaints were assessed for eligibility by research assistants who were midwives working at the gynaecology clinic. Women below 18 years of age, women in their puerperium and those with a referral diagnosis of fistulous incontinence were excluded from the study at this point. The objectives of the study were explained to those eligible to partake in the study prior to consulting their physicians by research assistants who had been trained to administer the questionnaires. The vast majority of questionnaires were administered through verbal translation into the local Asante Twi language as most participants had little or no English reading and comprehension skills while only a handful were self-administered in English. Translation of the questionnaire into the local language was done at the same time of the interview. Written informed consent were obtained from those willing to participate in the study.

Inclusion criteria comprised all women who accessed care at the gynaecology clinic irrespective of presenting complaints during the study period and consented to participate in the study.

Exclusion criteria comprised i) women declining to give consent ii) women below 18 years of age iii) women with confirmed pregnancy during the study period iv) women in their puerperium during the study period v) women with a referral diagnosis of fistulous incontinence during the study period vi) women responding 'NO' to the screening question "have you experienced involuntary leakage of urine in the past one month" were excluded from completing the ICIQ-SF(the second part of the questionnaire).

Data was collected using an orally-administered two-part questionnaire. Part one was for socio-demographic data (age, educational level, marital status, occupation), reasons for referral, general medical history and health habits (Body Mass Index, diabetes mellitus, hypertension, chronic cough, chronic constipation, smoking, consumption of alcohol, tea/coffee and carbonated drinks), and obstetric and gynaecologic history (gravidity, parity, mode of delivery, perineal injury, menopausal status, history of pelvic surgery, history of vaginal surgery). These variables were studied because of their reported association with non-fistulous incontinence \[[@pone.0237518.ref002], [@pone.0237518.ref006]--[@pone.0237518.ref009]\].

The second part of the questionnaire was made up of the International Consultation on Incontinence Questionnaire--Short Form (ICIQ-SF) \[[@pone.0237518.ref024]\]. This symptom questionnaire is made up of three scored questions regarding frequency of urinary incontinence (scored from 0 to 5), amount of leakage (scored from 0 to 6), and overall inconvenience (scored from 0 to 10). These three items sum up to give an overall score from 0 to 21 points, which has been graded by Klovning A et al. \[[@pone.0237518.ref025]\] as slight (1--5), moderate (6--12), severe (13--18), and very severe (19--21). A score of 0 indicates no incontinence symptoms. A fourth question of the ICIQ-SF, designed to elucidate type of urinary incontinence, is unscored. A screening question \"have you experienced any involuntary loss of urine in the past one month?\" was asked prior to completing the ICIQ-SF. Responders answering \"yes\" to the screening question proceeded to answer the four items on the ICIQ-SF. Those answering \"no\" to the screnning question did not complete the ICIQ-SF. The screening question was added in order not to burden responders without incontinence with the task of completing the ICIQ-SF.The ICIQ-SF, as used, has not been validated in the Ghanaian population.

Data was double-entered in SPSS version 20 (IBM, Armonk, NY, USA) and analysed using Stata 13 (Stata Corp, College Station, Texas, USA) after consistency checks. The data was summarized using frequencies and means with standard deviation and range

Associations between urinary incontinence and exposure variables were analyzed using chi-square test for categorical data and t-test for continuous data. Variables found to be statistically significant in the univariate analysis (i.e. p \< 0.1) were included in a multivariate model to explore their independent associations with incontinence status and adjusted odds ratios with 95% confidence intervals estimated. All exposures with p value \<0.05 in the multivariate analysis were considered significant.

The study was approved by the committee for Human Research, Publication and Ethics (CHRPE) of the Kwame Nkrumah University of Science and Technology (CHRPE/AP/239/14). Consent was also sought and obtained from Komfo Anokye Teaching Hospital's administration. Written Informed consent was obtained from all eligible participants. All clients were assigned a study number and no personal identifiers were used.

Results and discussions {#sec003}
=======================

Results {#sec004}
-------

Between 1^st^ January 2015 and 31^st^ March 2015, a total of 748 women were assessed for study eligibility. Of the 438 women deemed eligible, 400 were recruited into the study (see [Fig 1](#pone.0237518.g001){ref-type="fig"}).

![Profile of participant recruitment.](pone.0237518.g001){#pone.0237518.g001}

[Table 1](#pone.0237518.t001){ref-type="table"} shows the background characteristics of the study women. The mean age of respondents was 42.7 ±12.5 (mean ± SD) with a range of 19 to 88 years. Over three quarters of the respondents (304/400, 76%) had up to basic level education defined as 9 years of primary school education and 12.8% (51/400) were farmers.

10.1371/journal.pone.0237518.t001

###### Socio-demographic and obstetrics and gynaecologic characteristics of participants and their association with urinary incontinence.

![](pone.0237518.t001){#pone.0237518.t001g}

  Variable                           Incontinence   P-value     
  ---------------------------------- -------------- ----------- ---------
  **Age in groups (years)**          **N (%)**      **N (%)**   \<0.001
  18--39                             177(94.15)     11 (5.85)   
  40--59                             134(85.35)     23(14.65)   
  60 and above                       41(74.55)      14(25.45)   
  **Educational status**                                        0.002
  Up to basic education              259(85.20)     45(14.80)   
  Beyond Basic education             93(96.88)      3(3.13)     
  **Occupational status**                                       0.013
  Unemployed                         54(87.10)      8(12.90)    
  Traders/artisans                   226(90.76)     23(9.24)    
  Civil/public servants              34(89.47)      4(10.53)    
  Farmers                            38(74.51)      13(25.49)   
  **Marital status**                                            \<0.001
  Single                             72(97.30)      2(2.70)     
  Married/cohabiting                 219(89.02)     27(10.98)   
  Divorced                           29(85.29)      5(14.71)    
  widow                              32(69.57)      14(30.43)   
  **Gravidity**                                                 0.001
  0                                  74(94.87)      4(5.13)     
  1--4                               174(91.10)     17(8.90)    
  5 or more                          104(79.39)     27(20.61)   
  **Parity**                                                    \<0.001
  0                                  107(93.04)     8(6.96)     
  1--4                               169(92.35)     14(7.65)    
  5 or more                          76(74.51)      26(25.49)   
  **Mode of delivery**                                          0.312
  Only SVD                           196(84.48)     36(15.52)   
  Only C/S                           16(94.12)      1(5.88)     
  SVD +C/S                           33(91.67)      3(8.33)     
  **Number of vaginal deliveries**                              \<0.001
  1                                  50(98.04)      1(1.96)     
  2--4                               110(89.43)     13(10.57)   
  5 or more                          69(73.40)      25(26.60)   
  **Perineal injuries**                                         0.174
  No injury                          208(89.66)     24(10.34)   
  Injury                             137(85.09)     24(14.91)   
  **Menopausal status**                                         \<0.001
  No                                 275(92.28)     23(7.72)    
  Yes                                77(75.49)      25(24.51)   
  **Hysterectomy**                                              0.447
  No hysterectomy                    320(87.67)     45(12.33)   
  Had hysterectomy                   25(92.59)      2(7.41)     
  **Vaginal surgery**                                           0.526
  No vaginal surgery                 334(88.13)     45(11.87)   
  Had vaginal surgery                9(81.82)       2(18.18)    

The most common referral diagnosis was fibroid uterus (103/400, 25.8%) (See [Fig 2](#pone.0237518.g002){ref-type="fig"}). Only 0.75% (3/400) of the study women reported with a referral diagnosis of urinary incontinence. However, with questionnaire administration, urinary incontinence prevalence was 12% (48/400) (95% CI 8.80%-15.19%). A third (16/48, 33.3%) of respondents with incontinence had urgency incontinence, 22.9% (11/48), had stress urinary incontinence and about a fifth (10/48, 20.8%) had mixed incontinence. Furthermore, more than a third of incontinent women (18/48, 38%) experienced leakage of urine all the time, 21% (10/48) leaked urine once a day, while 8% (4/48) leaked several times a day. The amount of leakage was reportedly small for half of them (24/48, 50%), moderate for a third (16/48, 33%) and large for the remaining (8/48, 17%).

![Referral diagnoses of study participants (%).](pone.0237518.g002){#pone.0237518.g002}

On the overall interference with everyday life scale which ranged from 0 to 10 (with 0 representing no inconvenience and 10 representing a great deal of inconvenience) only 2% (1/48) of incontinent women reported no interference with daily life. Approximately 31% (15/48) reported mild interference with daily life whiles about 42% of incontinent women said urinary incontinence moderately interfered with their daily life. Interference of urinary incontinence with everyday life of affected women is shown in [Table 2](#pone.0237518.t002){ref-type="table"} below.

10.1371/journal.pone.0237518.t002

###### Interference of urinary incontinence with everyday life of affected women.

![](pone.0237518.t002){#pone.0237518.t002g}

  ICIQ-SF interference with everyday life Score   N       \%
  ----------------------------------------------- ------- -------
  0 (not at all)                                  1/48    2.08
  1--3 (mild)                                     15/48   31.25
  4--6 (moderate)                                 20/48   41.67
  7--9 (severe)                                   9/48    18.75
  10 (great extent)                               3/48    6.25

The mean ICIQ score of incontinent women was 11.60 ± 5.03 (mean ±SD) with a range of 3 to 21. The proportion of incontinent women by ICIQ score is shown in [Fig 3](#pone.0237518.g003){ref-type="fig"}.

![Proportion of incontinent women by severity of incontinence (ICIQ score).](pone.0237518.g003){#pone.0237518.g003}

In the univariate analysis (see Tables [1](#pone.0237518.t001){ref-type="table"} and [3](#pone.0237518.t003){ref-type="table"}), age, level of education, marital status, occupation, BMI, gravidity, parity, number of vaginal deliveries, menopausal status, Diabetes Mellitus, chronic cough and smoking were significantly associated with urinary incontinence. Adjusting for the effect of other variables in the multivariate analysis, age (P = 0.02), history of chronic cough (P = 0.01) and educational status of women (P = 0.04) were associated with the occurrence of urinary incontinence.

10.1371/journal.pone.0237518.t003

###### Medical history and health habits of study women and their association with urinary incontinence.

![](pone.0237518.t003){#pone.0237518.t003g}

  Variables                                                            Incontinence   P-value     
  -------------------------------------------------------------------- -------------- ----------- -------
  **Body mass index**                                                  **N (%)**      **N (%)**   0.054
  Non obese                                                            224(85.82)     37(14.18)   
  Obese[^a^](#t003fn001){ref-type="table-fn"}                          123(92.48)     10(7.52)    
  **Diabetes mellitus**                                                                           0.041
  Yes                                                                  27(77.14)      8(22.86)    
  No                                                                   322(88.95)     40(11.05)   
  **Chronic constipation**[^**b**^](#t003fn002){ref-type="table-fn"}                              0.602
  Yes                                                                  16(84.21)      3(15.79)    
  No                                                                   336(88.19)     45(11.81)   
  **Chronic cough**[^**c**^](#t003fn003){ref-type="table-fn"}                                     0.002
  Yes                                                                  14(66.67)      7(33.33)    
  No                                                                   338(89.18)     41(10.82)   
  **Smoking**                                                                                     0.066
  Yes                                                                  15(75.00)      5(25.00)    
  No                                                                   337(88.68)     43(11.32)   
  **Alcohol**                                                                                     0.205
  Yes                                                                  37(82.22)      8(17.78)    
  No                                                                   315(88.73)     40(11.27)   
  **Tea/coffee**                                                                                  0.639
  Nil/Occasionally (≤ 1 cup /week)                                     299(87.68)     42(12.32)   
  Frequently                                                           53(89.83)      6(10.17)    
  **Carbonated/fizzy drinks**                                                                     0.839
  Nil/Occasionally (≤ 1 bottle/week)                                   335(87.93)     46(12.07)   
  Frequently                                                           17(89.47)      2(10.53)    

^a^Obese: BMI ≥30kg/m^2^

^b^Chronic constipation: less than 3 bowel movements (stools) in a week for 6 months in the past one year

^c^Chronic cough: cough lasting 8 weeks or more in the last one year.

[Table 4](#pone.0237518.t004){ref-type="table"} shows the crude and adjusted odds ratio for factors associated with incontinence in the final model. Women aged ≥60 years were three and half times more likely to experience urinary incontinence compared to women aged 18--39 years. (AOR = 3.65, 95% CI1.48--9.00 P = 0.005). Again, women with a history of chronic cough in the past one year had approximately four times the odds of urinary incontinence compared to women without such history (AOR = 3.80 95% CI 1.36--10.58, P = 0.01). Having education beyond the basic level was however protective against urinary incontinence (AOR = 0.27 95% CI 0.08--0.96 P = 0.04). Almost all incontinent women (47/48, 97.9%) reported urinary incontinence interfere with their daily activities.

10.1371/journal.pone.0237518.t004

###### Crude and adjusted odds ratios of factors associated with urinary incontinence.

![](pone.0237518.t004){#pone.0237518.t004g}

  Variable                  Crude odds ratio   Adjusted odds ratio   95%CI (adjusted odds ratio)   P-Value
  ------------------------- ------------------ --------------------- ----------------------------- ---------
  **Age (years)**                                                                                  
  18--39                                                                                           
  40--59                    2.76               2.04                  0.93--4.46                    0.07
  ≥ 60                      5.49               3.65                  1.48--9.0                     0.005
  **Chronic cough**                                                                                
  No                                                                                               
  Yes                       4.12               3.80                  1.36--10.58                   0.01
  **Educational status**                                                                           
  ≤ Basic                                                                                          
  \>Basic                   0.19               0.28                  0.08--0.96                    0.04
  **Occupational status**                                                                          
  Unemployed                                                                                       
  Traders/Artisans          0.68               0.69                  0.22--2.10                    0.5
  Civil/Public servants     0.79               0.64                  0.11--3.64                    0.6
  Farmers                   2.30               1.32                  0.45--3.94                    0.6
  **Marital status**                                                                               
  Single                                                                                           
  Divorced                  6.20               2.0                   0.27--14.77                   0.49
  Married/cohabiting        4.40               2.6                   0.53--13.26                   0.23
  Widow                     15.75              4.7                   0.75--30.48                   0.09
  **BMI**                                                                                          
  Non-obese                                                                                        
  Obese                     0.49               0.61                  0.27--1.38                    0.2
  **Parity**                                                                                       
  0                                                                                                
  1--4                      1.10               0.7                   0.24--2.0                     0.5
  ≥5                        4.50               1.3                   0.39--4.2                     0.6
  **Menopause**                                                                                    
  No                                                                                               
  Yes                       3.8                1.57                  0.62--4.01                    0.33
  **Diabetes Mellitus**                                                                            
  No                                                                                               
  Yes                       0.41               0.78                  0.27--2.25                    0.6
  **Smoking**                                                                                      
  No                                                                                               
  Yes                       0.38               0.39                  0.08--1.72                    0.2

Discussion {#sec005}
==========

This cross-sectional study was conducted to assess the prevalence of urinary incontinence among women visiting an out-patient gynaecologic clinic, determine factors associated with its occurrence as well as its self-reported interference with everyday life activities of those affected. The overall prevalence of urinary incontinence was 12% though only 1% of study population were referred with a diagnosis of urinary incontinence. Urgency incontinence was the commonest form of incontinence with most women grading their incontinence as either moderate or severe.

The overall prevalence of urinary incontinence of 12% in this study falls within the reported global prevalence of 4.8% - 58.4% \[[@pone.0237518.ref002]\] and is similar to the 12.2% \[[@pone.0237518.ref020]\] and 14.6% \[[@pone.0237518.ref008]\] prevalence reported among Nigerians and Black women in United States of America respectively. It was however lower compared to the 41.5%, prevalence rate of demonstrable stress urinary incontinence reported in another Ghanaian study \[[@pone.0237518.ref023]\] which required participants to present with a full bladder before the test. It is possible some respondents had an uncomfortably full bladder predisposing to leaks with cough (occurrence of demonstrable stress incontinence) even though that may not be routine.

Again, the prevalence rate from the present study was also lower than the 21.4% \[[@pone.0237518.ref018]\] and 39% \[[@pone.0237518.ref019]\] reported in studies from Nigeria. The relatively narrow definition of urinary incontinence used in the present study compared to such definitions as "ever leaked urine in the past" and "had any leakage of urine occurred in the past one year" mostly used in these studies may account for the disparity. Assuming a common definition in studies assessing prevalence of non-fistulous urinary incontinence may be a first step towards obtaining a true global or regional prevalence. Such a common definition could be further modified to accommodate age and other appropriate differences.

Less than 1% of the study population had a referral diagnosis of incontinence. It is possible that women with incontinence did not report the condition to their primary physicians out of embarrassment or did not find their conditions bothersome or life threatening as previously reported \[[@pone.0237518.ref018], [@pone.0237518.ref026]\]. Some women may also consider the condition as part of aging, may be afraid of the complications of treatment, do not know what help is available or where to seek help \[[@pone.0237518.ref018], [@pone.0237518.ref026]\].

The common types of urinary incontinence recorded in this study were urgency (33.3%), stress (22.9%), and mixed (20.8%). This is consistent with findings from previous studies that identified stress, urgency and mixed incontinence as the three main subtypes of incontinence in women \[[@pone.0237518.ref012], [@pone.0237518.ref013], [@pone.0237518.ref017]--[@pone.0237518.ref019]\]. Studies however differ on which type is the most prevalent. This study identifies urgency incontinence as the commonest type similar to findings of Badejoko et al. \[[@pone.0237518.ref017]\], but differs from other studies in the sub-region that identified stress incontinence as the most common \[[@pone.0237518.ref018], [@pone.0237518.ref019]\].

Almost all the incontinent women reported that urinary incontinence interfere with their everyday life activity with more than half of them giving a score of 5 or more as reported in other studies \[[@pone.0237518.ref027], [@pone.0237518.ref028]\]. The ICIQ-SF, though limited in its assessment of impact on quality of life associated with incontinence, may be taken as a proxy for assessment of the quality of life of affected women.

Women aged ≥60 years were three and half times more likely to experience urinary incontinence compared to women aged 18--39 years. This finding compares favourably with previous studies that found age associations with urinary incontinence \[[@pone.0237518.ref029], [@pone.0237518.ref030]\]. The aged may be prone to the development of urinary incontinence due to hypoestrogenism, decreased urethral closure pressure and the development of detrusor overactivity \[[@pone.0237518.ref031]\]. In addition impaired mobility and increased nocturnal urine production may contribute to the development of urinary incontinence \[[@pone.0237518.ref031]\]. Some studies however did not find age to be significantly associated with urinary incontinence \[[@pone.0237518.ref027], [@pone.0237518.ref032]\].

The study found women with a history of chronic cough in the past year were about four times more likely to experience urinary incontinence compared to women without such a history and was consistent with previous reports \[[@pone.0237518.ref026]\]. Chronic coughs predispose to frequent increases in intra-abdominal pressure which in turn leads to weakness of the pelvic floor muscles and other supporting structures \[[@pone.0237518.ref033]\]. This finding however contrasts with findings in another study \[[@pone.0237518.ref032]\] where chronic cough was not linked to urinary incontinence.

The present study showed a significant association between level of education and urinary incontinence (p = 0.04). Women with education beyond the basic level were less likely to experience urinary incontinence compared to women with education up to the basic level. The apparent protective effect of higher education may be two-fold. The 2014 Ghana Demographic and Health Survey shows that the fertility rate is inversely related to women's educational attainment, decreasing from 6.2 among women with no education to 2.6 among women with secondary education or higher \[[@pone.0237518.ref034]\]. Secondly, women with lower education are more likely to engage in manual work like trading and farming that involve heavy lifting which causes constant rise in intra-abdominal pressure compared to those with higher education. Recurrent vaginal delivery and constant increase in intra-abdominal pressure may result in potentially irreversible anatomic and functional changes in the pelvic floor support structures leading to hypermobility and increased risk of stress incontinence. This finding differed from that of a Turkish study where educational status of women was not independently associated with urinary incontinence \[[@pone.0237518.ref030]\].

Parity was not associated with incontinence in the present study. This is in agreement with some studies \[[@pone.0237518.ref028]\] but inconsistent with others \[[@pone.0237518.ref027], [@pone.0237518.ref033]\].

The study findings are based on self-reported responses which could be a limitation. However, there is confidence in the results on grounds that affected women would be forthcoming with information on their affliction with urinary incontinence. It is also possible the questionnaire underestimated the burden of urinary incontinence as it has not been validated previously in the Ghanaian population as done elsewhere \[[@pone.0237518.ref035], [@pone.0237518.ref036]\]. Any bias emanating from the different routes of questionnaire administration is considered negligible as the vast majority were orally administered and is not expected to adversely affect the study findings. Policy and advocacy measures aimed at educating women and the general population on the potential causes, prevention and treatment of non-fistulous urinary incontinence are needed. Also, women should be encouraged to report the condition to clinicians when affected. Further studies are needed to validate the ICIQ-SF tool against urodynamic studies in Ghana and to assess the health seeking behaviour of women with urinary incontinence.

Supporting information {#sec006}
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###### Prevalence of incontinence dataset.
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Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Peter F.W.M. Rosier, M.D. PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and

<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants.

Please ensure you have provided sufficient details to replicate the analyses such as:

a\) the recruitment date range (month and year),

b\) a description of any inclusion/exclusion criteria that were applied to participant recruitment and

c\) a description of how participants were recruited.

3\. Thank you for including your ethics statement:

\'Ethical clearance was obtained from the Committee for Human Research, Publication and Ethics (CHRPE) of the Kwame Nkrumah University of Science and Technology (CHRPE/AP/239/14).\'

a\. Please amend your current ethics statement to confirm that your named institutional review board or ethics committee specifically approved this study.

b\. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the "Ethics Statement" field of the submission form (via "Edit Submission").

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to [http://journals.plos.org/plosone/s/submission-guidelines\#loc-human-subjects-research](about:blank#loc-human-subjects-research)

4\. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: [http://journals.plos.org/plosone/s/supporting-information](about:blank)

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: I Don\'t Know

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Thank you for submitting this manuscript

\- Please change urge incontinence to urgency incontinence

\- No need to add a question to the validated questionnaire and you can simply put it in the exclusion criteria of patients.

\- Why should you put the term non-fistulous in the title? You can actually mention the prevalence of urinary incontinence in the Ghana hospital.

Reviewer \#2: Methodology- highlight the inclusion criteria

Results- elaborate on the impact of urinary incontinence on the lifestyle, there should be a table for it

Reference- Reference 18 should be written properly

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0237518.r002

Author response to Decision Letter 0

2 Jun 2020

EDITORS/REVIEWERS COMMENTS AND RESPONSES

ACADEMIC EDITOR

1, Referring to lines 71 to 73, can you rephrase? I think that I understand that you mean: (NF)UI is more studied in industrialized countries but I may be wrong.

Authors response: we have rephrased the statements to remove all ambiguities. The statement now reads "Non-fistulous urinary incontinence has been studied extensively in Europe, China and United States of America".

2, Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming.

Authors response: All supporting files have been named according to the editorial requirements of PLOS ONE's journal as

"S1_Fig.tif

S2_Fig.tif

S3_Fig.tif

S1_Table.docx

S1_File.pdf

S2_File.dta"

3, In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants.

Please ensure you have provided sufficient details to replicate the analyses such as:

a\) the recruitment date range (month and year),

b\) a description of any inclusion/exclusion criteria that were applied to participant recruitment and

c\) a description of how participants were recruited.

Authors response: Additional details about recruitment period, inclusion and exclusion criteria and recruitment procedures have been provided in the methodology section of the manuscript. The following paragraph;

"All women attending the gynaecology clinic during the study period were assessed for eligibility by midwives who were research assistants and trained on questionnaire administration with its translation into the local dialect (Asante Twi). Study objectives were explained to participants and written informed consent obtained. Exclusion criteria comprised i) declining to give consent, ii) age below 18 years, iii) pregnancy at presentation, iv) women in the puerperium during the study period and v) women with a referral diagnosis of fistulous incontinence during the study period".

as written in the original manuscript has been rewritten in the revised manuscript as

"Between 1st January 2015 and 31st March 2015, all women accessing care at the gynaecology clinic irrespective of presenting complaints were assessed for eligibility by research assistants who were midwives working at the gynaecology clinic. Women below 18 years of age, women in their puerperium and those with a referral diagnosis of fistulous incontinence were excluded from the study at this point. The objectives of the study were explained to those eligible to partake in the study prior to consulting their physicians by the research assistants who have been trained to administer the questionnaires in English and the local (Asante Twi) language. Written informed consent were obtained from those willing to participate in the study and the questionnaire administered to them by the research assistants

Inclusion criteria comprised All women who assessed care at the gynaecology clinic irrespective of presenting complaints during the study period and consented to participate in the study.

Exclusion criteria comprised i) women declining to give consent ii) women below 18 years of age iii) women with confirmed pregnancy during the study period iv) women in their puerperium during the study period v) women with a referral diagnosis of fistulous incontinence during the study period vi) women responding 'NO' to the screening question "have you experienced involuntary leakage of urine in the past one month" were excluded from completing the ICIQ-SF(the second part of the questionnaire)."

4\. Thank you for including your ethics statement:

\'Ethical clearance was obtained from the Committee for Human Research, Publication and Ethics (CHRPE) of the Kwame Nkrumah University of Science and Technology (CHRPE/AP/239/14).\'

a\. Please amend your current ethics statement to confirm that your named institutional review board or ethics committee specifically approved this study.

b\. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the "Ethics Statement" field of the submission form (via "Edit Submission").

Authors response: The statement has been amended to read "The study was approved by the committee for Human Research, Publication and Ethics (CHRPE) of the Kwame Nkrumah University of Science and Technology (CHRPE/AP/239/14)" and same has been added to the "Ethics Statement" field of the submission form.

5, Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly.

Authors response: Caption for supporting information files has been added at the end of the manuscript and all supporting information files listed in accordance with the editorial requirements of PLOS ONE as shown below. In addition, all in-text citations have been updated to match accordingly.

Supporting information

S1 Fig. Profile of participant recruitment

S2 Fig. Referral diagnoses of study participants (%).

S3 Fig. Proportion of incontinent women by severity of incontinence (ICIQ score)

S1 Table. Prevalence of urinary incontinence questionnaire

S1 File. ICIQ-UI Short Form

S2 File. prevalence of incontinence dataset

REVIEWER \#1

Thank you for submitting this manuscript

1\. Please change urge incontinence to urgency incontinence

Authors response: Urge Incontinence has been changed to urgency incontinence in the manuscript.

2\. No need to add a question to the validated questionnaire and you can simply put it in the exclusion criteria of patients.

Authors response: The point is noted. The manuscript has been revised with an addition to the exclusion criteria that states

"any participant that responded NO to the question {have you experienced any involuntary loss of urine in the past one month?} was excluded from completing the ICIQ-SF"

Subsequent to this modification, the phrase "modified version of ICIQ-SF"

has been revised to "ICIQ-SF".

3\. Why should you put the term non-fistulous in the title? You can actually mention the prevalence of urinary incontinence in the Ghana hospital.

Authors response: The term non-fistulous was added to highlight the point that the manuscript is not about fistulous incontinence which is more associated with obstructed labour and has been studied extensively in Ghana. We are of the opinion that using the term "non-fistulous" in the title will make the study easily identifiable if one is looking for such studies in Africa or Ghana.

REVIEWER \#2

1\. Methodology- highlight the inclusion criteria

Authors response: As suggested the manuscript has been revised to highlight the inclusion criteria with the inclusion of the statement

"Inclusion criteria comprised; All women who assessed care at the gynaecology clinic irrespective of presenting complaints during the study period and consented to participate in the study".

2\. Results- elaborate on the impact of urinary incontinence on the lifestyle, there should be a table for it

Authors response: The statement "On the overall interference with everyday life scale which ranged from 0 to 10 (with 0 representing no inconvenience and 10 representing a great deal of inconvenience), more than a half of the incontinent women (28/48, 58.3%) gave a score of 5 or more with 2% (1/48) giving a score of 0" has been reworded to read

"On the overall interference with everyday life scale which ranged from 0 to 10 (with 0 representing no inconvenience and 10 representing a great deal of inconvenience) only 2% (1/48) of incontinent women reported no interference with daily life. Approximately 31% (15/48) reported mild interference with daily life whiles about 42% of incontinent women said urinary incontinence moderately interfered with their daily life". In addition, Table 2 with the caption "interference of urinary incontinence with everyday life of affected women." has been inserted.

3\. Reference- Reference 18 should be written properly

Authors response: Reference 18 has been revised accordingly. It now reads

"Bello OO (2018) Prevalence of Non-fistulous Urinary Incontinence Among Nonparturient Women in A Tertiary Hospital. Journal of Woman\'s Reproductive Health 2: 35"

instead of

"Bello OO. JOURNAL OF WOMAN'S REPRODUCTIVE HEALTH". as was contained in the original manuscript.

###### 

Submitted filename: RESPONSE TO REVIEWERS.pdf

###### 

Click here for additional data file.

10.1371/journal.pone.0237518.r003
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Rosier
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© 2020 Peter F.W.M. Rosier
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Peter F.W.M. Rosier

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

13 Jul 2020

PONE-D-20-00947R1

Prevalence and determinants of non-fistulous urinary incontinence among Ghanaian women seeking gynaecologic care at a Teaching Hospital.

PLOS ONE

Dear Dr. Ofori,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

As you can see the review suggests some more changes. I would add that it is good to make clear in the discussion paragraphs that it is about women who visited the gynecological clinic. Sometimes the conclusions seem to generalize too much, as if it is a population screening.

===================

Please submit your revised manuscript by Aug 27 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

We look forward to receiving your revised manuscript.

Kind regards,

Peter F.W.M. Rosier, M.D. PhD

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: All comments have been addressed

Reviewer \#3: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Yes

Reviewer \#3: Partly

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: Yes

Reviewer \#3: I Don\'t Know

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: This manuscript can be published in its present form. all the suggested corrections have been implemented.

Reviewer \#3: Thank you for this contribution. This is a very appropriate study with a lack of epidemiological data in Africa.

Comments:

Major:

Materials and Methods: Line 137 and line 159: Author should consider to comment on the validity of the questionnaires used as a measuring instrument and if the questionnaires were translated into Asanti Twe language. Also to inform the reader the reason why orally administered questionnaire was used versus written answered questionnaires.

Discussion:

Line 357: Author claims parity was not associated with urinary incontinence but Table 4 indicates all of the population is parous. This will needs explanation

Line 359: The author may consider to comment on limitations or strenghts in the study:

i\) if local validated questionnaire was used and

ii\) written and self completed questionnaire versus orally administered questionnaire

Conclusion:

Line 365:The author should indicate if the assumption to educate clinicians re screening for urinary incontinence is valid from this study or if it still requires further research

Minor:Line 170: Spelling

References:

1\. To consider to use the most lately published article on Standardization of terminology

31\. This reference appears to be incomplete \... Could not access properly via Google scholar.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0237518.r004

Author response to Decision Letter 1

17 Jul 2020

RESPONSES TO REVIEWERS

• ACADEMIC EDITOR

1\. Academic made the following comment;

"I would add that it is good to make clear in the discussion paragraphs that it is about women who visited the gynaecological clinic. Sometimes the conclusions seem to generalize too much, as if it is a population screening."

Response: The statement in the first paragraph of the discussion segment has been reworded to make it clear. The original statement read;

"This cross-sectional study was conducted to assess the prevalence of urinary incontinence among women, factors associated with its occurrence as well as its self-reported interference with everyday life activities of those affected" (line 289-291).

It now reads;

"This cross-sectional study was conducted to assess the prevalence of urinary incontinence among women visiting an out-patient gynaecologic clinic, determine factors associated with its occurrence as well as its self-reported interference with everyday life activities of those affected"

(line 288-291)

• REVIEWER 3

MAJOR

1\. Reviewer 3 made the following extracted comment on line 137

".........and if the questionnaires were translated into Asanti Twe language. Also to inform the reader the reason why orally administered questionnaire was used versus written answered questionnaires."

Response : it has been clarified that the bulk of the questionnaires had to be orally administered by verbal translation from English into the local language because most respondents had little or no English reading and comprehension abilities. Only a handful were able to self-administer the English version but we cannot provide data on how many could self-administer since we did not count. It was not considered relevant to the work.

The portions of the manuscript reflecting the changes are indicated below.................

Lines 136-139 originally read as;

"physicians by the research assistants who have been trained to administer the questionnaires in English and the local (Asante Twi) language. Written informed consent were obtained from those willing to participate in the study and the questionnaire administered by the research assistants"

It now reads as (136-141);

"physicians by research assistants who had been trained to administer the questionnaires. The vast majority of questionnaires were administered through verbal translation into the local Asante Twi language as most participants had little or no English reading and comprehension skills while only a handful were self-administered in English. Written informed consent were obtained from those willing to participate in the study."

2\. Reviewer 3 made the following comment on line 159

Author should consider to comment on the validity of the questionnaires used as a measuring instrument

Response: The questionnaire used (ICIQ-SF) has not been validated in the Ghanaian population. This would require a comparison of its output with urodynamic studies as a gold standard test with measurement of certain metrics. As earlier stated, this has not been done in the Ghanaian population and our study did not include it.

This has been clarified in the methodology and in the discussion

The portions of the manuscript reflecting the changes are indicated below.................

Line 159-160 originally read as;

"This validated symptom questionnaire is made up of three scored questions....................."

It now reads as (lines 161-162);

"This symptom questionnaire is made up of three scored questions...................."

In addition, a new sentence has been introduced (lines 173-174) as;

"The ICIQ-SF, as used, has not been validated in the Ghanaian population."

Furthermore, under the Discussion, the use of a measuring tool that has not been validated in the population has been acknowledged as a limitation and also put up for further research.

A new sentence has been introduced in the last paragraph of the DISCUSSION (line 362-364): "It is also possible the questionnaire underestimated the burden of urinary incontinence as it has not been validated previously in the Ghanaian population as done elsewhere"

ALSO, lines 366-367 originally reading as: "Further studies are needed to assess the health seeking behaviour of women with urinary incontinence" has now been modified to read as;

(Lines 370-372) "Further studies are needed to validate the ICIQ-SF tool against urodynamic studies in Ghana and to assess the health seeking behaviour of women with urinary incontinence"

3\. Reviewer 3 made the following comment on line 357

Author claims parity was not associated with urinary incontinence but Table 4 indicates all of the population is parous. This will need explanation

Response: All the population was NOT parous as Table 1 shows 115 respondents with zero parity. Table 4 only shows Odds ratios and p-values for association (parity versus incontinence) for the parity groups 1-4 and ≥5 compared to the baseline of zero parity. We think therefore that line 357 should stand.

4\. Reviewer 3 made the following comment on line 359

The author may consider to comment on limitations or strengths in the study:

i\) if local validated questionnaire was used and

ii\) written and self completed questionnaire versus orally administered questionnaire

Response:

i\) Issues on the validity of the questionnaire and its implications have been addressed under No. 2

ii\) The question of self-administered questionnaire versus orally administered questionnaire has been addressed under No. 1. Since the vast majority of questionnaires were orally administered, limitations of selection bias arising from any disparity between the two routes is considered insignificant and will not impact negatively on the findings

A new sentence is introduced (lines 364-367) to reflect this stance as below;

"Any bias emanating from the different routes of questionnaire administration is considered negligible as the vast majority were orally administered and is not expected to adversely affect the study findings"

5\. Reviewer 3 made the following comment on line 365

The author should indicate if the assumption to educate clinicians re screening for urinary incontinence is valid from this study or if it still requires further research

Response: We have elected to do away with the recommendation in question.

Hence, lines 365-366 which originally read as;

"Policy guidelines should aim at educating clinicians to screen for the condition in women attending gynaecology clinics" has been eliminated.

MINOR

1\. The reviewer draws attention to a spelling error on line 170

Response:

The misspelt word "screnning" has been changed to "screening" and is now on line 172

2\. Reviewer 3 made the following comments on Reference 1.

"To consider to use the most lately published article on Standardization of terminology"

Response:

We have replaced the old reference

"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, et al. (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61: 37-49."

with the most lately published article on standardization of terminology.

"Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, et al. (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourology and Urodynamics: Official Journal of the International Continence Society 29: 4-20."

The reference list has been updated appropriately.

3\. Reviewer 3 made the following comments on reference 31.

"This reference appears to be incomplete \... Could not access properly via Google scholar".

Response:

We concede the point that the reference as appears in Google Scholar is incomplete. Unfortunately, we are not in a position to provide the additional information to make the reference complete at the moment. As a result, the old reference

" Cardozo L (1997) Urogynecology: the King\'s approach: WB Saunders Company." has been replaced with a more recent referrence;

"Gomelsky A, Dmochowski RR (2011) Urinary incontinence in the aging female: etiology, pathophysiology and treatment options. Aging Health 7: 79-88".

Subsequently the wording of that part of the manuscript has been amended as follows;

Line 331-334 originally read as;

"It has been reported that aging predisposes individuals to urinary incontinence due to reduction in bladder capacity, decreased urethral closure pressure and decreased ability to delay voiding"...

It now reads (line 331-335)

"The aged may be prone to the development of urinary incontinence due to hypoestrogenism, decreased urethral closure pressure and the development of urodynamic detrusor overactivity\... In addition impaired mobility and increased nocturnal urine production may contribute to the development of urinary incontinence"...

Thnak you

###### 

Submitted filename: RESPOSNSE TO REVIEWERS.docx.pdf
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© 2020 Peter F.W.M. Rosier
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This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

27 Jul 2020

PONE-D-20-00947R2

Prevalence and determinants of non-fistulous urinary incontinence among Ghanaian women seeking gynaecologic care at a Teaching Hospital.

PLOS ONE

Dear Dr. Ofori,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:

In agreement with the reviewers comments: Can you be slightly more precise in your methods, and adapt the abstract?

==============================

Please submit your revised manuscript by Sep 10 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at <plosone@plos.org>. When you\'re ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled \'Manuscript\'.
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Reviewer \#3: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#3: Partly

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#3: I Don\'t Know

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?
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RESPONSE TO REVIEWER No. 3

Reviewer \#3: Thank you for your response.

You have answered the questions and made some changes to the text, but some of the changes does not reflect in your abstract. This needs to be corrected

I feel the reader needs to be clearly informed in the methodology section if the ICIQ-SF was translated prior to the interview to Ghanaian language but not validated, or if the person who introduced the questionnaire translated the questionnaire into Ghanaian language at the same time of the interview.

Response:

The authors appreciate the reviewer's opinion and keen sense of detail in reviewing our work. Under Methods, It has been clarified that translation into the local language was done at the same time as the interview was being conducted.

The relevant section of the Methods section originally read as (lines 137-141);

"........The vast majority of questionnaires were administered through verbal translation into the local Asante Twi language as most participants had little or no English reading and comprehension skills while only a handful were self-administered in English. Written informed consent were obtained from those willing to participate in the study. "

It has now been revised to read as (139-144);

".......The vast majority of questionnaires were administered through verbal translation into the local Asante Twi language as most participants had little or no English reading and comprehension skills while only a handful were self-administered in English. Translation of the questionnaire into the local language was done at the same time of the interview. Written informed consent were obtained from those willing to participate in the study."

Additionally, relevant changes have also been effected in the abstract to reflect reviewer comments.

The abstract originally read as shown below;

The study assessed the prevalence and determinants of non-fistulous urinary incontinence among gynaecologic care seekers as well as its interference with everyday life activities of affected women.

A cross-sectional study involving 400 women was conducted in a tertiary facility. Urinary incontinence was assessed using the International Consultation on Incontinence Questionnaire-short form (ICIQ-SF). The data was analysed for proportions and associations between selected variables.

The prevalence of urinary incontinence was 12%, the common types being urgency (33.3%), stress (22.9%), and mixed (20.8%). Age ≥60 years compared to 18-39 years (OR 3.66 95%CI 1.48-9.00 P=0.005), and a history of chronic cough (OR 3.80 95% CI 1.36-10.58 P=0.01) were associated with urinary incontinence. Women with education beyond the basic level were 72% less likely to experience urinary incontinence (OR 0.28 95%CI 0.08-0.96 P=0.04). Urinary incontinence interferes with everyday life activities of most affected women.

Non-fistulous urinary incontinence is relatively common among gynaecologic care seekers yet very few women were referred with such a diagnosis. Physicians should be educated to screen all women seeking gynaecologic care for incontinence with the aim of identifying women with such conditions for appropriate treatment.

It has now been revised to read as;

The study assessed the prevalence and determinants of non-fistulous urinary incontinence among gynaecologic care seekers as well as its interference with everyday life activities of affected women.

A cross-sectional study involving 400 women was conducted in a tertiary facility in Ghana. Urinary incontinence was assessed using the International Consultation on Incontinence Questionnaire-short form (ICIQ-SF) which has not been validated locally. The questionnaire was administered mostly in the Asante Twi language with translation done at the time of the interview. The data was analysed for proportions and associations between selected variables.

The prevalence of urinary incontinence was 12%, the common types being urgency (33.3%), stress (22.9%), and mixed (20.8%). Age ≥60 years compared to 18-39 years (OR 3.66 95%CI 1.48-9.00 P=0.005), and a history of chronic cough (OR 3.80 95% CI 1.36-10.58 P=0.01) were associated with urinary incontinence. Women with education beyond the basic level were 72% less likely to experience urinary incontinence (OR 0.28 95%CI 0.08-0.96 P=0.04). Urinary incontinence interferes with everyday life activities of most affected women.

Non-fistulous urinary incontinence is relatively common among gynaecologic care seekers yet very few women were referred with such a diagnosis. Advocacy measures aimed at urging affected women to report the condition and educating the general population on potential causes, prevention and treatment are needed.

RESPONSE TO ACADEMIC EDITOR

In agreement with the reviewer's comments: Can you be slightly more precise in your methods, and adapt the abstract?

Response: The detail suggested by the reviewer has been included and the abstract revised to reflect all changes made to the body of the manuscript.

The relevant section of the Methods section originally read as (lines 137-141);

"........The vast majority of questionnaires were administered through verbal translation into the local Asante Twi language as most participants had little or no English reading and comprehension skills while only a handful were self-administered in English. Written informed consent were obtained from those willing to participate in the study. "

It has now been revised to read as (139-144);

".......The vast majority of questionnaires were administered through verbal translation into the local Asante Twi language as most participants had little or no English reading and comprehension skills while only a handful were self-administered in English. Translation of the questionnaire into the local language was done at the same time of the interview. Written informed consent were obtained from those willing to participate in the study."

Additionally, relevant changes have also been effected in the abstract to reflect reviewer comments.

The abstract originally read as shown below;

The study assessed the prevalence and determinants of non-fistulous urinary incontinence among gynaecologic care seekers as well as its interference with everyday life activities of affected women.

A cross-sectional study involving 400 women was conducted in a tertiary facility. Urinary incontinence was assessed using the International Consultation on Incontinence Questionnaire-short form (ICIQ-SF). The data was analysed for proportions and associations between selected variables.

The prevalence of urinary incontinence was 12%, the common types being urgency (33.3%), stress (22.9%), and mixed (20.8%). Age ≥60 years compared to 18-39 years (OR 3.66 95%CI 1.48-9.00 P=0.005), and a history of chronic cough (OR 3.80 95% CI 1.36-10.58 P=0.01) were associated with urinary incontinence. Women with education beyond the basic level were 72% less likely to experience urinary incontinence (OR 0.28 95%CI 0.08-0.96 P=0.04). Urinary incontinence interferes with everyday life activities of most affected women.

Non-fistulous urinary incontinence is relatively common among gynaecologic care seekers yet very few women were referred with such a diagnosis. Physicians should be educated to screen all women seeking gynaecologic care for incontinence with the aim of identifying women with such conditions for appropriate treatment.

It has now been revised to read as;

The study assessed the prevalence and determinants of non-fistulous urinary incontinence among gynaecologic care seekers as well as its interference with everyday life activities of affected women.

A cross-sectional study involving 400 women was conducted in a tertiary facility in Ghana. Urinary incontinence was assessed using the International Consultation on Incontinence Questionnaire-short form (ICIQ-SF) which has not been validated locally. The questionnaire was administered mostly in the Asante Twi language with translation done at the time of the interview. The data was analysed for proportions and associations between selected variables.

The prevalence of urinary incontinence was 12%, the common types being urgency (33.3%), stress (22.9%), and mixed (20.8%). Age ≥60 years compared to 18-39 years (OR 3.66 95%CI 1.48-9.00 P=0.005), and a history of chronic cough (OR 3.80 95% CI 1.36-10.58 P=0.01) were associated with urinary incontinence. Women with education beyond the basic level were 72% less likely to experience urinary incontinence (OR 0.28 95%CI 0.08-0.96 P=0.04). Urinary incontinence interferes with everyday life activities of most affected women.

Non-fistulous urinary incontinence is relatively common among gynaecologic care seekers yet very few women were referred with such a diagnosis. Advocacy measures aimed at urging affected women to report the condition and educating the general population on potential causes, prevention and treatment are needed.
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